1 – 65 of 65
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2014
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Review: The future of cell therapies and brain repair: Parkinson's disease leads the way.
(
- Contribution to journal › Scientific review
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
- 2009
-
Mark
Propagation of host disease to grafted neurons: Accumulating evidence
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
(
- Contribution to journal › Article
-
Mark
Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries.
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Protein-protein interactions in poly-Q disease model
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
Weight loss in Huntington's disease is related to the number of CAG repeats
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.17-17(
- Contribution to journal › Published meeting abstract
-
Mark
Weight loss in Huntington disease increases with higher CAG repeat number
(
- Contribution to journal › Article
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
- 2007
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation.
(
- Contribution to journal › Article
-
Mark
Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.
(
- Contribution to journal › Article
- 2006
-
Mark
High-fat diet impairs hippocampal neurogenesis in male rats.
(
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
(
- Contribution to journal › Letter
-
Mark
Enriched Environment Attenuates Cell Genesis in Subventricular Zone After Focal Ischemia in Mice and Decreases Migration of Newborn Cells to the Striatum.
(
- Contribution to journal › Article
- 2005
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
(
- Contribution to journal › Article
-
Mark
Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
(
- Contribution to journal › Article
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
- 2003
-
Mark
Neural transplantation for the treatment of Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents
(
- Contribution to journal › Article
- 2002
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(
- Contribution to journal › Letter
- 2001
-
Mark
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease
(
- Contribution to journal › Article
- 2000
-
Mark
Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
(
- Contribution to journal › Article
- 1999
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
-
Mark
Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts
(
- Contribution to journal › Article
-
Mark
Caspase inhibition reduces apoptosis and increases survival of nigral transplants
(
- Contribution to journal › Article
- 1997
-
Mark
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
- 1996
-
Mark
Fetal neocortical grafts placed in brain infarcts do not improve paw-reaching deficits in adult spontaneously hypertensive rats
(
- Contribution to journal › Article
- 1995
-
Mark
Neocortical grafts placed in the infarcted brain of adult rats: few or no efferent fibers grow from transplant to host
(
- Contribution to journal › Article
- 1994
-
Mark
Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue
(
- Contribution to journal › Article
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Functional integration of cortical grafts placed in brain infarcts of rats
(
- Contribution to journal › Article
-
Mark
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism
(
- Contribution to journal › Article
-
Mark
Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats
(
- Contribution to journal › Article
- 1992
-
Mark
Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain
(
- Contribution to journal › Article
-
Mark
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : PET [18F]6-L-fluorodopa studies in two patients with putaminal implants
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : one-year clinical and neurophysiological observations in two patients with putaminal implants
(
- Contribution to journal › Article
- 1991
-
Mark
Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease
(
- Contribution to journal › Article
- 1990
-
Mark
Chapter 83 Neural transplantation in Parkinson's disease : the Swedish experience
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
In reply : Fetal brain grafts and Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
(
- Contribution to journal › Article
- 1989
-
Mark
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
(
- Contribution to journal › Article
-
Mark
Intracerebral xenografts of dopamine neurons : the role of immunosuppression and the blood-brain barrier
(
- Contribution to journal › Article
- 1988
-
Mark
Fetal dopamine-rich mesencephalic grafts in Parkinson's disease
(
- Contribution to journal › Letter
- 1987
-
Mark
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease
(
- Contribution to journal › Article